Cart
sales@molnova.com
Lomustine
CAS No. 13010-47-4
Lomustine ( CCNU; NCI C04740; NSC 79037 )
Catalog No. M11209 CAS No. 13010-47-4
Lomustine is an Alkylating Drug. The mechanism of action of lomustine is as an Alkylating Activity.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 45 | In Stock |
|
| 200MG | 77 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLomustine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLomustine is an Alkylating Drug. The mechanism of action of lomustine is as an Alkylating Activity.
-
DescriptionLomustine is an Alkylating Drug. The mechanism of action of lomustine is as an Alkylating Activity.
-
SynonymsCCNU; NCI C04740; NSC 79037
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylating; Stathmin-4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number13010-47-4
-
Formula Weight233.70
-
Molecular FormulaC9H16ClN3O2
-
Purity>98%(HPLC)
-
SolubilityWater:111 mg/L
-
SMILESO=C(NC1CCCCC1)N(CCCl)N=O
-
Chemical Name1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rassnick KM, et al. J Vet Intern Med, 1999, 13(6), 601-605.
molnova catalog
related products
-
Cisplatin
A chemotherapy agent that interferes with DNA replication and kills cancer cells; induces growth arrest and/or apoptosis in most cancer cell types; an alkylating agent for treatment of a number of cancers.
-
Alchemix
A dual action as an alkylating agent and topoisomerase inhibitor with potent activity against anthracycline- and cisplatin-resistant tumor cancer.
-
CM03
CM03 is a G-quadruplex-binding compound that potently inhibits cell growth in PDAC cell lines (MIA PaCa-2 IC50=19 nM).
